Drugs for Neglected Diseases Initiative, North America Inc.
Drugs for Neglected Diseases Initiative, North America Inc.
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Drugs for Neglected Diseases Initiative, North America Inc.? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
The Drugs for Neglected Diseases initiative (DNDi), North America supports DNDi's global vision and mission to develop new drugs, or new formulations of existing drugs for patients suffering from the most communicable diseases. Acting in the public interest, DNDi bridges existing R&D gaps in essential drugs for these diseases by initiating and coordinating drug R&D projects in collaboration with the international research community, the public sector, the pharmaceutical industry, and other partners.
About
Grants to research and development for neglected diseases: DNDi North America raises funds to support DNDi's research and development (R&D) activities in order to contribute to the achievement of DNDi's goal of delivering 16-18 new treatments for neglected patients by 2023 and establishing a robust pipeline of new potential drug candidates. DNDi now has over 30 projects in its pipeline, including 13 potential new chemical entities(nces), and has delivered seven treatments that are already in the hands of millions of patients.
Interesting data from their 2020 990 filing
The purpose of the non-profit, as set forth in the filing, is “The mission of dndi north america is to contribute to the achievement of dndi's global objectives, in particular to strenghten and expand dndi's scientific, policy advocacy, fundraising, and communications efforts in north america by (a) providing focused support for specific r&d projects and business/partner development activities in north america;(b) achieving concrete policy changes in north america to create a more favorable environment for needs-driven r&d for neglected diseases;(c) mobilizing public and private funds in north america to support dndi's mission;(d) increasing dndi's profile and visibility in north america, thereby drawing greater public attention to the need for neglected disease r&d.”.
When discussing its purpose, they were characterized as: “The drugs for neglected diseases initiative (dndi), north america supports dndi's global vision and mission to develop new drugs, or new formulations of existing drugs for patients suffering from the most neglected diseases. acting in the public interest, dndi bridges existing r&d gaps in essential drugs for these diseases by initiating and coordinating drug r&d projects in collaboration with the international research community, the public sector, the pharmaceutical industry, and other partners.”.
- The state in which the non-profit is legally authorized to operate is DE, as reported.
- The filing confirms that the non-profit's address in 2020 was 40 RECTOR STREET 16TH FLOOR, NEW YORK, NY, 10006.
- The form of the non-profit reports 12 employees as of 2020.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is $33,737.
- The organization has 7 independent voting members.
- The organization was formed in 2007.
- The organization pays $1,518,437 in salary, compensation, and benefits to its employees.
- The organization pays $779,806 in fundraising expenses.